Literature DB >> 22432674

Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population.

Sarah C Boyd1, Eugene Athan, N Deborah Friedman, Andrew Hughes, Aaron Walton, Peter Callan, Anthony McDonald, Daniel P O'Brien.   

Abstract

OBJECTIVE: To describe the epidemiology, clinical features and diagnosis of Mycobacterium ulcerans infection occurring on the Bellarine Peninsula in Victoria. DESIGN, SETTING AND PATIENTS: Analysis of prospectively collected data on all patients with confirmed M. ulcerans infection reported from the Bellarine Peninsula and managed at Barwon Health between 1 January 1998 and 2 September 2011. MAIN OUTCOME MEASURES: Proportion of cases by age group and sex; duration of symptoms; number, type and site of lesions; proportions diagnosed by polymerase chain reaction (PCR) testing and mycobacterial cultures.
RESULTS: We identified 180 sequential cases of M. ulcerans infection: 42 cases in 1998-2004 and 138 in 2005-2011. Median patient age was 61 years (range, 1-94 years), and 49% of patients were male. Duration of symptoms before diagnosis varied from 2 to 270 days (median, 42 days). At presentation, 95% of patients had single lesions. Lower limbs were the most common site of lesions (61%), followed by upper limbs (34%); 40% occurred over a joint. Most lesions presented as ulcers (87%). Compared with the rest of the study population, patients aged > 60 years were more likely to have multiple lesions (odds ratio [OR], 8.1; 95% CI, 1.0-176.2; P = 0.04), and patients aged < 15 years were less likely to have lesions over a joint (OR, 0.2; 95% CI, 0.0-1.0; P = 0.02). Upper limb lesions were more common (OR, 2.2; 95% CI, 1.1-4.3; P = 0.02) and lower limb lesions less common (OR, 0.5; 95% CI, 0.5-0.9; P = 0.01) in male than female patients. Lesion swabs were PCR-positive in 99% of those tested, and positive on mycobacterial culture in 19%. Lesion biopsy samples were PCR-positive in 95% and mycobacterial culture-positive in 47%.
CONCLUSIONS: M. ulcerans infections are increasing in the Bellarine Peninsula. They usually present as single ulcerative lesions on limbs, commonly over joints. Age and sex influence clinical presentation, and PCR of lesions has high diagnostic sensitivity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22432674     DOI: 10.5694/mja12.10087

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  25 in total

1.  Comparative Genomics Shows That Mycobacterium ulcerans Migration and Expansion Preceded the Rise of Buruli Ulcer in Southeastern Australia.

Authors:  Andrew H Buultjens; Koen Vandelannoote; Conor J Meehan; Miriam Eddyani; Bouke C de Jong; Janet A M Fyfe; Maria Globan; Nicholas J Tobias; Jessica L Porter; Takehiro Tomita; Ee Laine Tay; Torsten Seemann; Benjamin P Howden; Paul D R Johnson; Timothy P Stinear
Journal:  Appl Environ Microbiol       Date:  2018-04-02       Impact factor: 4.792

2.  Buruli ulcer disease in travelers and differentiation of Mycobacterium ulcerans strains from northern Australia.

Authors:  Caroline J Lavender; Maria Globan; Paul D R Johnson; Patrick G P Charles; Grant A Jenkin; Niladri Ghosh; Benjamin M Clark; Marianne Martinello; Janet A M Fyfe
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

3.  Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.

Authors:  N Deborah Friedman; Eugene Athan; Aaron L Walton; Daniel P O'Brien
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

4.  Clinical Epidemiology of Buruli Ulcer from Benin (2005-2013): Effect of Time-Delay to Diagnosis on Clinical Forms and Severe Phenotypes.

Authors:  Carlos Capela; Ghislain E Sopoh; Jean G Houezo; René Fiodessihoué; Ange D Dossou; Patrício Costa; Alexandra G Fraga; João F Menino; Rita Silva-Gomes; Edgard M Ouendo; Fernando Rodrigues; Jorge Pedrosa
Journal:  PLoS Negl Trop Dis       Date:  2015-09-10

5.  Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.

Authors:  Daniel P O'Brien; Mike Robson; N Deborah Friedman; Aaron Walton; Anthony McDonald; Peter Callan; Andrew Hughes; Richard Rahdon; Eugene Athan
Journal:  BMC Infect Dis       Date:  2013-09-05       Impact factor: 3.090

Review 6.  Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).

Authors:  Rie R Yotsu; Marty Richardson; Norihisa Ishii
Journal:  Cochrane Database Syst Rev       Date:  2018-08-23

7.  Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the Mapé Basin of Cameroon.

Authors:  Martin W Bratschi; Miriam Bolz; Jacques C Minyem; Leticia Grize; Fidèle G Wantong; Sarah Kerber; Earnest Njih Tabah; Marie-Thérèse Ruf; Ferdinand Mou; Djeunga Noumen; Alphonse Um Boock; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13

8.  Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes.

Authors:  Daniel P O'Brien; N Deborah Friedman; Raquel Cowan; James Pollard; Anthony McDonald; Peter Callan; Andrew Hughes; Eugene Athan
Journal:  PLoS Negl Trop Dis       Date:  2015-12-02

9.  Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.

Authors:  N Deborah Friedman; Eugene Athan; Andrew J Hughes; Masoomeh Khajehnoori; Anthony McDonald; Peter Callan; Richard Rahdon; Daniel P O'Brien
Journal:  PLoS Negl Trop Dis       Date:  2013-07-18

10.  The incubation period of Buruli ulcer (Mycobacterium ulcerans infection).

Authors:  Jason A Trubiano; Caroline J Lavender; Janet A M Fyfe; Simone Bittmann; Paul D R Johnson
Journal:  PLoS Negl Trop Dis       Date:  2013-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.